228 related articles for article (PubMed ID: 18026570)
21. Angiotensin-(1-7) induces ovulation and steroidogenesis in perfused rabbit ovaries.
Viana GE; Pereira VM; Honorato-Sampaio K; Oliveira CA; Santos RA; Reis AM
Exp Physiol; 2011 Sep; 96(9):957-65. PubMed ID: 21666031
[TBL] [Abstract][Full Text] [Related]
22. Angiotensin-(1-7) potentiates responses to bradykinin but does not change responses to angiotensin I.
Greco AJ; Master RG; Fokin A; Baber SR; Kadowitz PJ
Can J Physiol Pharmacol; 2006 Nov; 84(11):1163-75. PubMed ID: 17218981
[TBL] [Abstract][Full Text] [Related]
23. Angiotensin 1-7 Protects against Angiotensin II-Induced Endoplasmic Reticulum Stress and Endothelial Dysfunction via Mas Receptor.
Murugan D; Lau YS; Lau CW; Mustafa MR; Huang Y
PLoS One; 2015; 10(12):e0145413. PubMed ID: 26709511
[TBL] [Abstract][Full Text] [Related]
24. An orally active formulation of angiotensin-(1-7) produces an antithrombotic effect.
Fraga-Silva RA; Costa-Fraga FP; De Sousa FB; Alenina N; Bader M; Sinisterra RD; Santos RA
Clinics (Sao Paulo); 2011; 66(5):837-41. PubMed ID: 21789389
[TBL] [Abstract][Full Text] [Related]
25. Activation of the MAS receptor by angiotensin-(1-7) in the renin-angiotensin system mediates mesenteric vasodilatation in cirrhosis.
Grace JA; Klein S; Herath CB; Granzow M; Schierwagen R; Masing N; Walther T; Sauerbruch T; Burrell LM; Angus PW; Trebicka J
Gastroenterology; 2013 Oct; 145(4):874-884.e5. PubMed ID: 23796456
[TBL] [Abstract][Full Text] [Related]
26. Chronic treatment with angiotensin-(1-7) improves renal endothelial dysfunction in apolipoproteinE-deficient mice.
Stegbauer J; Potthoff SA; Quack I; Mergia E; Clasen T; Friedrich S; Vonend O; Woznowski M; Königshausen E; Sellin L; Rump LC
Br J Pharmacol; 2011 Jul; 163(5):974-83. PubMed ID: 21371005
[TBL] [Abstract][Full Text] [Related]
27. Mas receptor overexpression increased Ang-(1-7) relaxation response in renovascular hypertensive rat carotid.
Olivon VC; Aires RD; Santiago LB; Ramalho LZ; Cortes SF; Lemos VS
Peptides; 2015 Sep; 71():250-8. PubMed ID: 26256416
[TBL] [Abstract][Full Text] [Related]
28. Complete blockade of the vasorelaxant effects of angiotensin-(1-7) and bradykinin in murine microvessels by antagonists of the receptor Mas.
Peiró C; Vallejo S; Gembardt F; Palacios E; Novella S; Azcutia V; Rodríguez-Mañas L; Hermenegildo C; Sánchez-Ferrer CF; Walther T
J Physiol; 2013 May; 591(9):2275-85. PubMed ID: 23459756
[TBL] [Abstract][Full Text] [Related]
29. The Mas receptor mediates modulation of insulin signaling by angiotensin-(1-7).
Muñoz MC; Giani JF; Burghi V; Mayer MA; Carranza A; Taira CA; Dominici FP
Regul Pept; 2012 Aug; 177(1-3):1-11. PubMed ID: 22561450
[TBL] [Abstract][Full Text] [Related]
30. Endothelial dysfunction through genetic deletion or inhibition of the G protein-coupled receptor Mas: a new target to improve endothelial function.
Peiró C; Vallejo S; Gembardt F; Azcutia V; Heringer-Walther S; Rodríguez-Mañas L; Schultheiss HP; Sánchez-Ferrer CF; Walther T
J Hypertens; 2007 Dec; 25(12):2421-5. PubMed ID: 17984663
[TBL] [Abstract][Full Text] [Related]
31. Angiotensin-(1-7) decreases skeletal muscle atrophy induced by angiotensin II through a Mas receptor-dependent mechanism.
Cisternas F; Morales MG; Meneses C; Simon F; Brandan E; Abrigo J; Vazquez Y; Cabello-Verrugio C
Clin Sci (Lond); 2015 Mar; 128(5):307-19. PubMed ID: 25222828
[TBL] [Abstract][Full Text] [Related]
32. Angiotensin-(1-7) recruits muscle microvasculature and enhances insulin's metabolic action via mas receptor.
Fu Z; Zhao L; Aylor KW; Carey RM; Barrett EJ; Liu Z
Hypertension; 2014 Jun; 63(6):1219-27. PubMed ID: 24711523
[TBL] [Abstract][Full Text] [Related]
33. Vascular relaxation, antihypertensive effect, and cardioprotection of a novel peptide agonist of the MAS receptor.
Savergnini SQ; Beiman M; Lautner RQ; de Paula-Carvalho V; Allahdadi K; Pessoa DC; Costa-Fraga FP; Fraga-Silva RA; Cojocaru G; Cohen Y; Bader M; de Almeida AP; Rotman G; Santos RA
Hypertension; 2010 Jul; 56(1):112-20. PubMed ID: 20479330
[TBL] [Abstract][Full Text] [Related]
34. Angiotensin-(1-7) enhances LTP in the hippocampus through the G-protein-coupled receptor Mas.
Hellner K; Walther T; Schubert M; Albrecht D
Mol Cell Neurosci; 2005 Jul; 29(3):427-35. PubMed ID: 15950155
[TBL] [Abstract][Full Text] [Related]
35. Angiotensin-(1-7) counteracts angiotensin II-induced dysfunction in cerebral endothelial cells via modulating Nox2/ROS and PI3K/NO pathways.
Xiao X; Zhang C; Ma X; Miao H; Wang J; Liu L; Chen S; Zeng R; Chen Y; Bihl JC
Exp Cell Res; 2015 Aug; 336(1):58-65. PubMed ID: 26101159
[TBL] [Abstract][Full Text] [Related]
36. Angiotensin II type 1 receptor blockade restores angiotensin-(1-7)-induced coronary vasodilation in hypertrophic rat hearts.
Souza ÁP; Sobrinho DB; Almeida JF; Alves GM; Macedo LM; Porto JE; Vêncio EF; Colugnati DB; Santos RA; Ferreira AJ; Mendes EP; Castro CH
Clin Sci (Lond); 2013 Nov; 125(9):449-59. PubMed ID: 23718715
[TBL] [Abstract][Full Text] [Related]
37. Transforming growth factor type-β inhibits Mas receptor expression in fibroblasts but not in myoblasts or differentiated myotubes; Relevance to fibrosis associated to muscular dystrophies.
Cofre C; Acuña MJ; Contreras O; Morales MG; Riquelme C; Cabello-Verrugio C; Brandan E
Biofactors; 2015; 41(2):111-20. PubMed ID: 25809912
[TBL] [Abstract][Full Text] [Related]
38. The ACE2-angiotensin-(1-7)-Mas axis protects against pancreatic cell damage in cell culture.
Wang J; Liu R; Qi H; Wang Y; Cui L; Wen Y; Li H; Yin C
Pancreas; 2015 Mar; 44(2):266-72. PubMed ID: 25426615
[TBL] [Abstract][Full Text] [Related]
39. Angiotensin-(1-7) inhibits sodium transport via Mas receptor by increasing nitric oxide production in thick ascending limb.
Dibo P; Marañón RO; Chandrashekar K; Mazzuferi F; Silva GB; Juncos LA; Juncos LI
Physiol Rep; 2019 Mar; 7(5):e14015. PubMed ID: 30839176
[TBL] [Abstract][Full Text] [Related]
40. Role of angiotensin-(1-7) in gastroprotection against stress-induced ulcerogenesis. The involvement of mas receptor, nitric oxide, prostaglandins, and sensory neuropeptides.
Magierowski M; Jasnos K; Pawlik M; Krzysiek-Maczka G; Ptak-Belowska A; Olszanecki R; Kwiecien S; Korbut R; Brzozowski T
J Pharmacol Exp Ther; 2013 Dec; 347(3):717-26. PubMed ID: 24049058
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
